CTAP (TFA) (103429-32-9 free base)
Product Specifications
Target
Opioid Receptor
Related Pathways
Neuroscience, Endocrinology/Hormones, GPCR/G Protein
Purity
0.9962
Bioactivity
CTAP (TFA) (103429-32-9 free base) is a potent, highly selective, and brain-penetrant antagonist of the μ-opioid receptor with IC50 of 3.5 nM. It displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP (TFA) (103429-32-9 free base) can be used for the study of L-DOPA-induced dyskinesia (LID)
Smiles
CC(O)C1C(NC(C(NC(C(N)=O)C(O)C)=O)C(C)(C)SSCC(NC(C(N)CC2=CC=CC=C2)=O)C(NC(CC3=CC=C(O)C=C3)C(NC(CC4=CNC5=CC=CC=C54)C(NC(CCC/N=C(N)\N)C(N1)=O)=O)=O)=O)=O.O=C(O)C(F)(F)F
Molecular Formula
C53H70F3N13O13S2
Molecular Weight
1218.33
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
43939091 4x 500 ng
SLC22A13-set siRNA/shRNA/RNAi Lentivector (Human)
Sign In for Pricing
View Details 
MBS6480947-01 0.1 mL
HLA Class 2 Antigen DRA, CT (HLA Class II Histocompatibility Antigen DR alpha Chain, HLA-DRA, HLA-DRA1, FLJ51114, MHC Class II Antigen DRA, MLRW) (MaxLight 405)
Sign In for Pricing
View Details MBS6480947-02 5x 0.1 mL
HLA Class 2 Antigen DRA, CT (HLA Class II Histocompatibility Antigen DR alpha Chain, HLA-DRA, HLA-DRA1, FLJ51114, MHC Class II Antigen DRA, MLRW) (MaxLight 405)
Sign In for Pricing
View Details